RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS)

Clinical trials for RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) explained in plain language.

Never miss a new study

Get alerted when new RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) trials appear

Sign up with your email to follow new studies for RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 3

MS patients over 40 may ditch heavy drugs in landmark trial

Disease control Not yet recruiting

This study tests whether people with relapsing-remitting multiple sclerosis (RRMS) who are over 40 and have been stable on strong anti-CD20 drugs for at least 3 years can safely switch to milder treatments without their disease flaring up. Half of the 250 participants will stay o…

Matched conditions: RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS)

Phase: PHASE3 • Sponsor: University Hospital, Montpellier • Aim: Disease control

Last updated May 26, 2026 10:32 UTC

RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS)

Get alerted when new RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) trials appear

MS patients over 40 may ditch heavy drugs in landmark trial